These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31464291)

  • 1. [Pharmacoeconomic analysis of the neuroprotective medicines in the treatment of ischemic stroke].
    Yagudina RI; Kulikov AY; Krylov VA; Solovieva EY; Fedin AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):60-68. PubMed ID: 31464291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with ischemic stroke].
    Zhuravleva MV; Shchukin IA; Fidler MS; Prokofiev AB; Serebrova SY; Vasyukova NS; Demchenkova EY; Arkhipov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12. Vyp. 2):60-66. PubMed ID: 33449535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mexidol, Cytoflavin, and succinic acid derivatives as antihypoxic, anti-ischemic metabolic modulators, and ergogenic aids in athletes and consideration of their potential as performance enhancing drugs.
    Jędrejko K; Catlin O; Stewart T; Muszyńska B
    Drug Test Anal; 2024 Feb; ():. PubMed ID: 38403950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modern strategies of protection of hypoxic-ischemic brain damage].
    Yanishevsky SN; Tsygan NV; Golokhvastov SY; Andreev RV; Litvinenko IV; Karpova OS; Yakovleva VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12. Vyp. 2):78-86. PubMed ID: 29411750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy and safety of Mexidol Forte 250 as part of long-term sequential therapy in patients with carotid stroke].
    Strelnikova IA; Svetkina AA; Androfagina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):54-58. PubMed ID: 32307431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modern approaches to neuroprotective treatment of ischemic stroke].
    Stakhovskaya LV; Tyutyumova EA; Fedin AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8. Vyp. 2):75-80. PubMed ID: 28980585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)].
    Stakhovskaya LV; Shamalov NA; Khasanova DR; Melnikova EV; Agafiina AS; Golikov KV; Bogdanov EI; Yakupova AA; Roshkovskaya LV; Lukinykh LV; Lokshtanova TM; Poverennova IE; Shepankevich LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3. Vyp. 2):55-65. PubMed ID: 28665371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of mexidol across age groups in the acute and early recovery stages of hemispheric ischemic stroke (results of additional sub-analysis of a randomized double blind multicenter placebo-controlled study, in parallel groups trial EPICA)].
    Stakhovskaya LV; Mkhitaryan EA; Tkacheva ON; Ostroumova TM; Ostroumova OD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8. Vyp. 2):49-57. PubMed ID: 33016677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The impact of therapy with Mexidol on neurological deficit and functional outcome in patients with ischemic stroke: a systematic review and meta-analysis].
    Voznyuk IA; Kolomentsev SV; Morozova EM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12. Vyp. 2):49-60. PubMed ID: 38148698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of blood rheology by patients with acute ischemic stroke with Mexidol administration].
    Plotnikov DM; Stegmeier MN; Aliev OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3. Vyp. 2):76-82. PubMed ID: 31184628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].
    Fedin AI; Zakharov VV; Tanashyan MM; Chukanova EI; Madzhidova EN; Shchepankevich LA; Ostroumova OD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):7-16. PubMed ID: 34932280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined neuroprotection in the treatment of post-stroke aphasia].
    Safronova MN; Kovalenko AV; Mizurkina OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):20-26. PubMed ID: 31464285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Economic aspects of diabetic macular edema treatment at regional level in Russian Federation].
    Serpik VG; Arsyutov DG; Gulidova EG; Zolotarev AV; Iskhakova AG; Kulikov AY; Faizrakhmanov RR; Tselina ME; Yagudina RI
    Vestn Oftalmol; 2017; 133(6):138-148. PubMed ID: 29319681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies of antihypoxic, neuroprotective and analgesic action of succinate-containing drugs].
    Iasnetsov VV; Prosvirova EP; Tsublova EG; Iasnetsov VV; Motin VG; Karsanova SK
    Aviakosm Ekolog Med; 2012; 46(6):41-5. PubMed ID: 23457968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The trial of the efficacy and safety of sequential therapy with Mexidol forte 250 in acute and early recovery stages of hemispheric ischemic stroke].
    Loskutnikov MA; Domashenko MA; Vakin TM; Trushina IA; Konstantinov VI; Proskuryakova OS; Shchukina EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10):22-26. PubMed ID: 33244953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of ethylmethylhydroxypyridine in the rehabilitation treatment of poststroke patients].
    Zhuravleva MV; Prokofiev AB; Arkhipov VV; Serebrova SY; Gorodetskay GI; Demidova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3):92-96. PubMed ID: 32323950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of a cohort single-center randomized study of the modulating effect of the drug Mexidol in the rehabilitation of patients who suffered acute cerebral insufficiency].
    Belkin AA; Belkin VA; Vasilchenko IE; Pinchuk EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):108-117. PubMed ID: 38676685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats.
    Povarnina PY; Volkova AA; Gudasheva TA; Seredenin SB
    Bull Exp Biol Med; 2017 Dec; 164(2):173-176. PubMed ID: 29181667
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.